SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. Gone are the days of visiting a doctor’s office to determine whether ...
WASHINGTON - The U.S. Food and Drug Administration has granted emergency use authorization for another COVID-19 at-home test. The agency approved the Quidel QuickVue At-Home COVID-19 Test, allowing ...
Designed for symptomatic individuals within six days of symptom onset, the QuickVue COVID-19 test is cleared for use in individuals aged 14 or older when self-testing, and in those aged two and older ...
Anyone who tests positive with an antigen test in Italy is supposed to get a PCR test to confirm the result. - AFP Anyone who tests positive with an antigen test in Italy is supposed to get a PCR test ...
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback